key: cord-0764104-5bcp9cvj
authors: Yagi, Yohsuke; Asami, Yutaro; Kyoya, Mitsuki; Yokota, Takanori
title: Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination
date: 2021-11-16
journal: Neurol Sci
DOI: 10.1007/s10072-021-05714-0
sha: 013c8fc848d639bfa6e247d9891f3b6ad639b749
doc_id: 764104
cord_uid: 5bcp9cvj

nan

coronavirus 2 (SARS-CoV-2) according to the polymerase chain reaction test. Blood tests for the risk factors of venous thrombosis such as antiphospholipid antibody and protein S/C showed no remarkable abnormality, and the screening test for antibodies against PF4-heparin was negative. After heparin treatment, his headache was relieved in 2 weeks, with sinus thrombosis partially disappearing.

CVST after SARS-CoV-2 vaccines are divided into a CVST in the setting of the vaccine-induced immune thrombotic thrombocytopenia syndrome (VITT), mainly related to adenovirus vector-based vaccines, and a CVST without VITT characteristics, related also to mRNA-based vaccines [4] . This case was a CVST not related to VITT.

In the UK (https:// www. gov. uk/ gover nment/ publi catio ns/ coron avirus-covid-19-vacci ne-adver se-react ions), USA (Vaccine Adverse Event Reporting System [VAERS]: https:// wonder. cdc. gov/ vaers. html), Europe (http:// www. adrre ports. eu/ en/ index. html), and Japan (https:// www. mhlw. go. jp/ stf/ shingi/ shingi-kousei_ 284075. html), the occurrence of CVST after mRNA-based COVID-19 vaccinations has been reported to the authorities. In the analysis of thrombotic events reported to the WHO VigiBase, CVST, as well as PE and DVT, occurred after the injection of mRNA-based and adenovirus vector vaccines [5] , but their causal relationship was not supported in a US epidemiologic study [6] . However, mild CVST events, as seen in our patient, might be possibly excluded in these analyses because headache may be too mild to be spontaneously reported. Therefore, our case suggests that the precise relationship between CVST and COVID-19 vaccination remains unclear, and its evaluation should include mild cases. Although excessive concern to post-vaccination headache is inappropriate, we recommend performing brain CT or MRI to evaluate CVST for patients whose headache lasts for > 1 week after vaccination, even for mild ones. 

Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination

US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26. COV2.S vaccination

Magnetic resonance imaging of thrombosed dural sinuses

Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia

Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase

Cerebral venous sinus thrombosis is not significantly linked to COVID-19 vaccines or non-COVID vaccines in a large multi-state health system